Olmesartan medoxomil
Benicar, Edarbi (olmesartan medoxomil) is a small molecule pharmaceutical. Olmesartan medoxomil was first approved as Benicar on 2002-04-25. It is used to treat diabetic nephropathies, heart failure, hypertension, and left ventricular dysfunction in the USA. It has been approved in Europe to treat hypertension. The pharmaceutical is active against type-1 angiotensin II receptor.
| Trade Name | Edarbi |
|---|---|
| Common Name | Olmesartan medoxomil |
| Indication | diabetic nephropathies, heart failure, hypertension, left ventricular dysfunction |
| Drug Class | Angiotensin II receptor antagonists |
